These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38234119)
1. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma. Deng SZ; Wu X; Kong L; Cheng B; Dai L J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119 [TBL] [Abstract][Full Text] [Related]
2. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
3. Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma. Ji L; Liang S; Cheng Y; Gao R; Yan W; Pang F; Zhang F Cancer Biomark; 2024; 40(3-4):319-342. PubMed ID: 39213052 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics. Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175 [TBL] [Abstract][Full Text] [Related]
5. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma. Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077 [TBL] [Abstract][Full Text] [Related]
6. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma. Xu Z; Li X; Pan L; Tan R; Ji P; Tang H J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473 [TBL] [Abstract][Full Text] [Related]
7. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y Front Immunol; 2022; 13():922195. PubMed ID: 35935989 [TBL] [Abstract][Full Text] [Related]
8. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis]. Zhao G; Li CX; Guo C; Zhu H Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337 [TBL] [Abstract][Full Text] [Related]
9. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma. Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics. Zhang YY; Mao MH; Han ZX Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632 [TBL] [Abstract][Full Text] [Related]
11. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma. Yue K; Yao X BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322 [TBL] [Abstract][Full Text] [Related]
12. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis. Qi L; Tang Z Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853 [TBL] [Abstract][Full Text] [Related]
13. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas. Shan L; Lu Y; Song Y; Zhu X; Xiang CC; Zuo ED; Cheng X Oxid Med Cell Longev; 2022; 2022():9529814. PubMed ID: 35910847 [TBL] [Abstract][Full Text] [Related]
14. A prognostic Risk Score model for oral squamous cell carcinoma constructed by 6 glycolysis-immune-related genes. Liu Y; Wang T; Li R BMC Oral Health; 2022 Aug; 22(1):324. PubMed ID: 35922788 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients. Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753 [TBL] [Abstract][Full Text] [Related]
16. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins. Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222 [TBL] [Abstract][Full Text] [Related]
17. Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach. Li S; Li H; Xu Y; Ning W; Hu S; Wei S; Song H; Sun J; Ziebolz D; Schmalz G; Hu X; Liu M Comput Math Methods Med; 2022; 2022():2203615. PubMed ID: 35222682 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma. Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767 [TBL] [Abstract][Full Text] [Related]
19. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden. Wu F; Du Y; Hou X; Cheng W BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327 [TBL] [Abstract][Full Text] [Related]
20. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation. Zhang G; Zhao X; Liu W Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]